Targeted cellular immunotherapy for T cell malignancies

被引：8
|
作者：
Palomero, Teresa [1 ,2 ]
Ferrando, Adolfo [1 ,2 ,3 ]
机构：
[1] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA
[2] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA
[3] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA
来源：
NATURE MEDICINE | 2017年 / 23卷 / 12期
关键词：
DIVERSITY; LYMPHOMA;
D O I：
10.1038/nm.4458
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In a recent study, Maciocia et al. develop a novel T cell receptor beta (TCRB) constant C1-chain-directed cellular immunotherapy for the treatment of T cell malignancies.
引用
收藏
页码：1402 / 1403
页数：2
相关论文
共 50 条
  • [31] A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies
    Newman, Haley
    Teachey, David T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [32] Recent advances in T-cell immunotherapy for haematological malignancies
    Rouce, Rayne H.
    Sharma, Sandhya
    Huynh, Mai
    Heslop, Helen E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 688 - 704
  • [33] Targeted Cancer Immunotherapy by Nanoparticle T Cell Engagers
    Lubben, Berit
    Alhallak, Kinan
    Sun, Jennifer
    Muz, Barbara
    Bash, Hannah
    Park, Chaelee
    Adebayo, Ola
    Achilefu, Samuel
    Dipersio, John F.
    Azab, Abdel K.
    FASEB JOURNAL, 2022, 36
  • [34] Anti-CD37 targeted immunotherapy of B-Cell malignancies
    Payandeh, Zahra
    Noori, Effat
    Khalesi, Bahman
    Mard-Soltani, Maysam
    Abdolalizadeh, Jalal
    Khalili, Saeed
    BIOTECHNOLOGY LETTERS, 2018, 40 (11-12) : 1459 - 1466
  • [35] Anti-CD37 targeted immunotherapy of B-Cell malignancies
    Zahra Payandeh
    Effat Noori
    Bahman Khalesi
    Maysam Mard-Soltani
    Jalal Abdolalizadeh
    Saeed Khalili
    Biotechnology Letters, 2018, 40 : 1459 - 1466
  • [36] Adoptive Immunotherapy for B-cell Malignancies with Autologous Chimeric Antigen Receptor Modified Tumor Targeted T Cells
    Park, Jae H.
    Brentjens, Renier J.
    DISCOVERY MEDICINE, 2010, 9 (47) : 277 - 288
  • [37] CD19-Targeted Chimeric Antigen Receptor-Modified T-Cell Immunotherapy for B-Cell Malignancies
    Turtle, C. J.
    Riddell, S. R.
    Maloney, D. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 252 - 258
  • [38] Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies
    Angelos, Mathew G.
    Patel, Ruchi P.
    Ruella, Marco
    Barta, Stefan K.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : 171 - 186
  • [39] Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies
    Maciocia, Paul Michael
    Wawrzyniecka, Patrycja
    Philip, Brian
    Ricciardelli, Ida
    Akarca, Ayse U.
    Onuoha, Shimobi
    Cole, David
    Sewell, Andrew
    Peggs, Karl S.
    Linch, David C.
    Marafioti, Teresa
    Pule, Martin A.
    BLOOD, 2016, 128 (22)
  • [40] Evaluation of T cell antigen receptor vaccines for active immunotherapy of T cell malignancies.
    Okada, CY
    Wong, C
    Denney, DW
    Levy, R
    BLOOD, 1995, 86 (10) : 2133 - 2133
12345